AUPH
Aurinia Pharmaceuticals Inc
NASDAQ: AUPH · HEALTHCARE · BIOTECHNOLOGY
$15.72
+3.22% today
Updated 2026-05-11
Market cap
$2.02B
P/E ratio
7.28
P/S ratio
6.78x
EPS (TTM)
$2.16
Dividend yield
—
52W range
$7 – $17
Volume
1.2M
Aurinia Pharmaceuticals Inc (AUPH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-21.03M | $-28.46M | $-17.39M | $-10.46M | $-4.34M | $-1.36M | $-6.55M | $-4.52M | $-16.90M | $-17.77M | $-18.71M | $-41.17M | $-51.61M | $-63.59M | $-69.86M | $-157.69M | $-79.53M | $-33.46M | $44.39M | $135.66M |
| Capital expenditures | $1.22M | $867413.00 | $336894.00 | $232069.00 | $84986.00 | $1.15M | $39202.00 | $104247.00 | $90000.00 | $50000.00 | $25000.00 | $25000.00 | $75000.00 | $101000.00 | $7.34M | $1.50M | $292000.00 | $718000.00 | $281000.00 | $252000.00 |
| Depreciation | $-867364.00 | $1.42M | $1.40M | $1.27M | $1.15M | $960822.00 | $851401.00 | $813321.00 | $1.52M | $1.56M | $1.48M | $1.46M | $1.56M | $1.17M | $1.37M | $2.76M | $2.71M | $11.65M | $19.45M | — |
| Stock-based comp | — | — | $489728.00 | — | — | $371204.00 | $276429.00 | $223522.00 | $2.19M | $3.22M | $1.38M | $4.24M | $6.86M | $7.41M | $17.45M | $31.24M | $32.30M | $45.31M | $31.60M | $14.68M |
| Free cash flow | $-22.25M | $-29.33M | $-17.73M | $-10.69M | $-4.42M | $-2.51M | $-6.59M | $-4.63M | $-16.99M | $-17.82M | $-18.74M | $-41.19M | $-51.69M | $-63.69M | $-77.20M | $-159.19M | $-79.82M | $-34.18M | $44.11M | $135.41M |
| Investing cash flow | $19.02M | $9.23M | $-333607.00 | $-163308.00 | $1.48M | $-1.15M | $-31161.00 | $-35688.00 | $-10.08M | $-23000.00 | $9.99M | $-8.00M | $-66000.00 | $7.78M | $-158.19M | $-103.87M | $-60.63M | $-6.71M | $39.26M | — |
| Financing cash flow | $-1.27M | $36.03M | $10.32M | $-9.61M | $4.64M | $2.28M | $716705.00 | $6.21M | $47.89M | $839000.00 | $42.62M | $175.15M | $4.01M | $243.85M | $194.38M | $221.11M | $2.43M | $-5.13M | $-49.09M | — |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $-33.67M | $-40.45M | — | — | — | — |